News & Articles

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

Pioneering new class of diagnostic product will transform fight against pandemic

Watch this on-demand webinar to understand how better research diagnostic methods can lead to improved treatment of congenital metabolopathies

The combination of the unique technologies aims to bring a novel angle to combat the global pandemic

The device enables researchers to analyze their cell cultures remotely, hence minimizing time spent in high-containment labs

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available

The IgA, IgG, and IgM assays are formatted for optimal functionality in diagnostic laboratories

The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

The new LabCollector LIMS pack aims to increase the rapidity and efficiency in COVID-19 tests management

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis

Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

Recent funding from the BARDA award helped the company accelerate development and validation

The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic